If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,045.00    -4.50 (-0.43%)
Bid:
1,044.50
Ask:
1,045.00
Spread: 0.50 (0.048%)
Market Cap: £3.36b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Update

5 Jul 2018 07:00

RNS Number : 6422T
Persimmon PLC
05 July 2018
 

TRADING UPDATE

 

THURSDAY 5 JULY 2018

 

Persimmon plc ("the Group") announces the following update ahead of its Half Year Results to 30 June 2018, which will be released on Tuesday 21 August 2018. This statement covers the period from 1 January 2018 to 30 June 2018.

 

Total revenues for the first six months of 2018 were £1.84bn, 5% higher than last year (2017: £1.75bn)¹. Housing revenues for the first six months of £1.74bn were 5% higher than the prior year (2017: £1.66bn) with new housing legal completion volumes increasing by 278 homes, or 3.6%, to 8,072 homes (2017: 7,794). The Group's new housing average selling price increased by 1.2% to c. £215,800 (2017: £213,262).

Persimmon is focussed on increasing its output of family housing at affordable prices in locations where people want to live and work. This has continued to support healthy trading with total enquiry levels running c. 6% ahead of the prior year. Our weekly private sales rate per site for the first half has continued to be strong at c. 0.78 from an average of c. 375 active sales outlets which was in line with last year. Consumer confidence remains resilient in our markets and attractive mortgage products provide compelling support to purchasers of new homes.

 

The value of the Group's total forward sales of new housing at 30 June 2018 of £1.68bn was 5% higher than last year (2017: £1.60bn) in addition to the increase of 5% in housing revenues legally completed in the first half. The Group has a strong platform to achieve further growth in the second half. The average selling price of the c.4,900 new homes sold forward into the private sales market was c. £236,700, c. 2% ahead of the prior year. The Group's new homes sold forward to its housing association partners at 30 June had an average selling price of c. £117,600.

 

The Group's sales activity in the second half will be supported by the current sales network of c. 370 outlets together with the planned opening of a further c.100 new sales outlets during the period.

 

We expect continued improvement in the Group's underlying housing operating margin in the first half of 2018 building on the performance of the Group in the second half of last year (2017 H2: 28.8%). Despite inflationary cost pressures, disciplined cost control and continued efficiency savings have supported this margin progression.

 

During the first half of the year, the Group has brought 45 new land parcels for the delivery of c. 11,000 new homes into the business in a land market that has continued to provide good quality opportunities. Our total land spend in the period was c. £343m (2017: £369m). We have successfully converted c. 3,000 plots from the Group's strategic land portfolio, which represents c. 37% of the Group's first half land consumption.

 

Our long-term commitment to return surplus capital to shareholders is central to the Group's strategy. On 27 February 2018 the Board announced enhanced payments under the Group's Capital Return Plan ("the Plan") of 235p per share over the next three years. For 2018 an additional payment of 125p per share or £389m was paid to shareholders on 29 March with a further 110p per share or £344m paid on 2 July. This increased commitment raised the total value of the Plan to c. £4.07bn, or £13.00 per share, to be returned to shareholders by the end of 2021. This represents an increase of c. 110% over the original value of the Plan at launch in 2012.

 

At 30 June the Group held £1,154m of cash (2017: £1,120m) prior to payment of the scheduled Capital Return of £344m on 2 July 2018.

 

The successful execution of Persimmon's strategy launched in 2012 has delivered the Group's strong financial position together with a high quality asset platform designed to place the business in a robust position as we continue to make progress into the future. The Group will continue to focus on building the new homes needed by communities right across the UK. We remain confident in the Group's future prospects.

 

 

Please Note

There will be a call for analysts at 0900 BST today. Please use the dial-in details below:

 

Telephone number: +44 (0)333 300 0804

PIN: 79720722#

Password: Persimmon

An audiocast of the call will be available on www.persimmonhomes.com/corporate from this afternoon.

For further information please contact:

 

Persimmon plc

Citigate Dewe Rogerson

Jeff Fairburn, Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Tel: +44 (0) 20 7638 9571 on the day

Tel: +44 (0) 1904 642 199 thereafter

Tel: +44 (0) 20 7638 9571

 

Footnote 1

IFRS 15 Revenue from Contracts with Customers became effective from 1 January 2018. In line with the explanation provided at Note 1 to the 2017 Financial Statements, the Group recognises revenue at the fair value of the consideration received or receivable on the legal completion of a newly built residential property sale. On applying IFRS 15 revenues will now include the fair value of consideration received or receivable on the sale of part exchange properties. Prior to the introduction of IFRS 15 revenues associated with the sale of part exchange properties were included as a reduction in cost of sales, as the purchase and sale of part exchange properties is regarded as a mechanism in support of selling newly built homes to existing home owners. Applying IFRS 15 results in an increase to both revenues and cost of sales. There is no change to the reported profit from operations but there is a reduction in the reported operating margin. Additionally, there is no impact on the Group's cash flows. The impact for the first half of 2018, together with comparatives for the 2017 financial year is as follows -

 

 

 

First Half

2018

First Half

2017

Full Year

2017

Housing revenues (as previously reported for 2017)

£1,742.0m

£1,662.2m

£3,422.3m

Part exchange revenues

£93.8m

£91.3m

£175.5m

Total revenues - post IFRS 15

£1,835.8m

£1,753.5m

£3,597.8m

 

Housing gross profit (as previously reported for 2017)

 

TBC*

 

£507.3m

 

£1,071.7m

Total gross profit - post IFRS 15

TBC*

£507.3m

£1,071.7m

Housing gross margin (as previously reported for 2017)

TBC*

30.5%

31.3%

Total gross margin - post IFRS 15

TBC*

28.9%

29.8%

Housing operating profit (as previously reported for 2017)

TBC*

£454.0m

£955.1m

Total operating profit - post IFRS 15

TBC*

£454.0m

£955.1m

Housing operating margin (as previously reported for 2017)

TBC*

27.3%

27.9%

Total operating margin - post IFRS 15

TBC*

25.9%

26.5%

Housing underlying operating profit (as previously reported for 2017)

TBC*

£459.4m

£966.1m

Total underlying operating profit - post IFRS 15

TBC*

£459.4m

£966.1m

Housing underlying operating margin (as previously reported for 2017)

TBC*

27.6%

28.2%

Total underlying operating margin - post IFRS 15

TBC*

26.2%

26.9%

 

* The profit and margin numbers for the current half year will be reported on release of the Half Year results to 30

June 2018 on Tuesday 21 August 2018.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGMGGNVDVGRZM
Date   Source Headline
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.